News

Concerns Mount for Hershey as Analysts Set Low Growth Forecasts

Concerns Mount for Hershey as Analysts Set Low Growth Forecasts

Redburn-Atlantic Initiates Coverage on Hershey

Recently, Redburn-Atlantic assessed the stock of Hershey (NYSE:HSY) with a Sell rating, proposing a target price of $165.00. This analysis has unveiled several critical issues, particularly within Hershey's North American market that may hinder growth.

Challenges in Chocolate Consumption

Despite Hershey's robust presence in chocolate sales, the firm outlined several factors influencing its growth. Rising health consciousness among consumers, along with stagnant chocolate consumption rates, has created a challenging environment. Increased competition further complicates the landscape, leading to greater skepticism regarding Hershey's market position.

Expected Modest Sales Growth

The analyst's outlook indicates an anticipated annual organic sales growth of just 1.4%, which is 60 basis points below market expectations. Particularly concerning is the forecast for Hershey's salty snacks division, accounting for roughly 10% of total sales. The cautious perspective suggests that while near-term sales may be bolstered through the expansion of salty snack offerings, the long-term viability of this segment is questionable.

Salty Snacks Division Prospects

Redburn-Atlantic's deep dive into the salty snacks category reveals disappointing market dynamics that may impede Hershey's success. Their projections suggest a long-term sales growth rate of 2.8% per annum, which is substantially lower than market consensus by 160 basis points.

Implications of Analyst Ratings

The report from Redburn-Atlantic paints a clear picture of the hurdles facing Hershey in both its chocolate and salty snacks sectors. With a Sell rating accompanied by a price target of $165.00, Redburn-Atlantic suggests that meaningful upside potential in Hershey's stock is unlikely at this point.

Market Reactions and Other Ratings

In the broader market context, Hershey's financial results and strategic moves have drawn attention from various financial institutions. While Bernstein SocGen Group maintains a Market Perform rating, Citi has adjusted its price target for Hershey to $181 while also recommending a Sell rating. Concerns linger regarding the upcoming third-quarter earnings report, with expectations that it may fall short of consensus predictions for organic sales growth and earnings per share (EPS).

Price Adjustments and Product Innovation

In an effort to combat the market challenges, Hershey has announced a significant price increase of 12% on nearly half of its product lines. Analysts at RBC suggest this strategy could bolster the company’s financial standing. Furthermore, Hershey has pivoted toward introducing alternative treats such as gummies and flavored crèmes, aligning with changing consumer preferences.

Recent Downgrades and Management Changes

Multiple financial houses, including UBS, Jefferies, and Barclays, have downgraded their ratings on Hershey, primarily due to declining chocolate volumes and inflated earnings expectations amidst ongoing cost pressures. In recent management updates, Hershey has appointed Michael Del Pozzo as the new President of its U.S. Confection segment, a change poised to lead growth initiatives in the domestic market.

Insights from InvestingPro

Further emphasizing the cautious sentiment surrounding Hershey, recent data from InvestingPro features a P/E ratio of 20.4. This aligns with observations noting that Hershey trades at a high P/E ratio in relation to its near-term earnings growth prospects, suggesting potential overvaluation. Nevertheless, Hershey's commitment to shareholders is underscored by its history of raising dividends for 14 consecutive years, yielding 2.97% currently and showcasing an impressive 32.24% growth in dividends over the past year.

Revenue Growth and Market Strategies

Despite the positive notes, Hershey faces stagnant growth challenges. Recent reports highlighted a mere 1.44% revenue growth over the past year, with a troubling 16.7% decline in quarterly revenues for Q2 2024. This supports the analysts' views on the modest organic growth projections.

Frequently Asked Questions

What was Redburn-Atlantic's rating for Hershey?

Redburn-Atlantic initiated coverage on Hershey with a Sell rating and a price target of $165.00.

What factors are affecting Hershey's growth?

Factors include stagnant chocolate consumption, increased health consciousness, and rising competition in the market.

What are the expected growth rates for Hershey's salty snacks?

The expected long-term sales growth for Hershey's salty snacks division is about 2.8% per annum, significantly below market consensus.

How has Hershey responded to market challenges?

Hershey has implemented a 12% price increase on half of its products and introduced new items like gummies and flavored crèmes.

What dividends has Hershey maintained?

Hershey has raised its dividends for 14 consecutive years, with a current yield of 2.97% and a growth of 32.24% over the last year.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Cloud Software Group Amends $2B Cash Tender Offer

Updated Category News Views 71

Cloud Software Group is stirring the pot with an amendment that'll have bondholders looking twice at their portfolios. On November 3, 2026, the company announced a tweak to its cash tender offer, bumping up the payment for its 9.00% Senior Secured Second Lien Notes due 2029. The payout now jumps from $1,017.50 to $1,022.50 for each $1,000 of principal. If you're holding...

Continue Reading
ACLM and eClinicalWorks Expand Lifestyle Medicine Reach

Updated Category News Views 92

Changing the Game with Lifestyle Medicine When it comes to healthcare, you're always going to have the skeptics grousing about the old ways. But what happens when you take an old idea and turbocharge it with modern tech? That's where the American College of Lifestyle Medicine (ACLM) and eClinicalWorks step in. They’re throwing a new wrench into the electronic health...

Continue Reading
STVN's GLP-1 Fumble Sparks Shareholder Scrutiny

Updated Category News Views 35

The Storm Hits Stevanato: GLP-1 Blues Well, ain't this a fine pickle for Stevanato Group S.p.A. (NYSE:STVN). November 3, 2026, turned into quite the ride for those holding STVN shares. A tough third-quarter report dropped like a ton of bricks, driving the shares down after they coughed up a lower outlook for GLP-1 volumes in 2027. If you've been in the game long enough,...

Continue Reading
Tamagotchi Turns 30: Roblox Event Connects Worlds

Updated Category News Views 17

A New Chapter for an Old Favorite Dust off your digital pets, folks! Tamagotchi is not just a thing of the past. It's busting out of its shell to celebrate a big 3-0 with a splash—and get this—on Roblox. Who would've thought a plastic egg with pixels would still be out there thriving in the ether of childhood nostalgia three decades later? But it is, and it’s taking...

Continue Reading
ROBOTWORLD 2026: AI Reshapes Industrial Horizons

Updated Category News Views 48

A Grand Gathering of Robotics Minds Walking into KINTEX, Seoul's suburban behemoth of an exhibition center, you'll find a buzz that rivals the excitement of a stock floor on earnings day. It's ROBOTWORLD 2026, a stage set for tech titans and ambitious startups alike, all throwing in their chips on AI and robotics. From November 4th to 7th, 402 companies hailing from 17...

Continue Reading
3M's Huge Settlement: Navigating A Looming Legal Fog

Updated Category News Views 94

The latest chapter in 3M’s legal saga reads like a courtroom drama, but this time, the company's shelling out big bucks to sidestep prolonged courtroom battles. They're committing to a $5.8 billion payout over several years, aiming to put a lid on a massive batch of PFAS-related lawsuits. It’s like they’re cleaning the spill with a velvet mop, but the trick is...

Continue Reading
DarioHealth Taps Palumbo to Drive Healthcare Evolution

Updated Category News Views 0

Strategic Leadership for an Evolving Market Prepare your portfolios, folks. DarioHealth Corp. (NASDAQ:DRIO) is gearing up to ride a seismic shift in healthcare. John R. Palumbo's appointment as Chairman of the Board marks a bold move as Dario looks to dominate the new convergence of consumer-directed and payer-funded healthcare. This isn't just a change of guard; it's a...

Continue Reading
VAB's Pharma Ad Guide: Emerging Trends and Insights

Updated Category News Views 191

Pharma's not just popping pills anymore; it's a whole show on multiscreen TV. The Video Advertising Bureau (VAB) just dropped a bombshell of a guide called The Pharmacy, diving into the state of pharmaceutical direct-to-consumer (DTC) advertising. Over the past year and a half, VAB's been grilling agencies, media folks, and anyone else with skin in the game to sketch the...

Continue Reading
SWFI's I20 Summit Spotlights 3,000 Promising Start-Ups

Updated Category News Views 101

Spotlight on Emerging Titans: The Future 100 Watchlist The Sovereign Wealth Fund Institute is rattling the investment cages with their latest stunt, the 'Future 100 Watchlist.' Hot off the press, this list is parading nearly 3,000 start-ups that are biting at the heels of future success. It's high stakes and higher hopes between December 11-16 at Miami's I20 Summit, where...

Continue Reading
Compass Faces Securities Fraud Suit: Deadline Looms

Updated Category News Views 45

Compass's Legal Rumble: Shareholders Take Note You know there’s trouble when a firm’s every effort at glassy-eyed optimism is slapped with a lawsuit. We've seen this song and dance far too often, and now Compass, Inc. (NYSE: COMP) takes center stage. Schall, Brown & Schwartz LLP is rallying the troops for a knock-down-drag-out class action lawsuit, accusing Compass of...

Continue Reading
s of Cautious Optimism - Continue Reading" aria-label="Continue reading: Farmer Sentiment Rises, Hints of Cautious Optimism"> Continue Reading